COLUMBUS, Ohio (WCMH) — Girls at Hilltonia Middle School got a hands-on experience in health care science Tuesday. After ...

Will the recent momentum be cut short following the biotech's Feb. 10 earnings release, or will it continue? Over the past ...

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported Q4 CY2025 results , with sales up 5.2% year on year to $7.93 ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19, ...

The University of Arkansas for Medical Sciences Institute for Community Health is training 25 doulas for 2026 to provide ...

With more than 15 years of experience, Simplicis delivers a data and workflow management platform designed to support complex experimental designs, including pooling, mixtures, and dynamic curve ...

A professor and chair of UAMS’ Department of Orthopaedic Surgery, C. Lowry Barnes was selected as one of four finalists in a ...

The new facility will cost $137 million and will house 18 research labs, four teaching labs, a 300-seat lecture hall, and ...